Substance
DARATUMUMAB
Global reference: every product and company linked to this substance.
- cas: 945721-28-8
- ncit: C74007
- rxnorm: 1721947
- unii: 4Z63YK6E0E
3003-005 · daratumumab [INN] · DARATUMUMAB [JAN] · DARATUMUMAB [USAN] · Daratumumab [WHO-DD] · DARZALEX · HUMAX-CD38 · HUMAXCD38
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| JOHNSON & JOHNSON COMMON STOCK | DARZALEX | Q2 2026 | $4.2B |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (1)
- DARZALEX · JOHNSON & JOHNSON COMMON STOCK